Difficulty: Medium
Average Score: 88%
Practice
While reviewing the medical record of a client with moderate dementia of the Alzheimer type, the nurse notes that the client has been receiving memantine. The nurse identifies this drug as which type?
Correct answer
C
Rationale
The correct answer is C: NMDA receptor antagonist. Memantine is a medication used in the treatment of Alzheimer's disease by blocking the NMDA receptors, which helps regulate glutamate activity in the brain. This action can improve cognitive function in individuals with dementia.
Choice A (Atypical antipsychotic) is incorrect because memantine is not classified as an antipsychotic medication. Choice B (Cholinesterase inhibitor) is incorrect because while cholinesterase inhibitors are also used in treating Alzheimer's disease, memantine works through a different mechanism by targeting NMDA receptors. Choice D (Benzodiazepine) is incorrect because benzodiazepines are not typically used in the treatment of Alzheimer's disease.
Choice A (Atypical antipsychotic) is incorrect because memantine is not classified as an antipsychotic medication. Choice B (Cholinesterase inhibitor) is incorrect because while cholinesterase inhibitors are also used in treating Alzheimer's disease, memantine works through a different mechanism by targeting NMDA receptors. Choice D (Benzodiazepine) is incorrect because benzodiazepines are not typically used in the treatment of Alzheimer's disease.